Currently, the poor validation of PD1 or PD-L1 expression scores is another component which complicates essentially treatment response prediction and cross-study comparisons.When analyzing endometrial cancer subgroups according to current guidelines, several associations can be observed. This evidence concerns the gene CD274 and endometrial cancer.